Cargando…

Vaccine chronicle in Japan

The concept of immunization was started in Japan in 1849 when Jenner’s cowpox vaccine seed was introduced, and the current immunization law was stipulated in 1948. There have been two turning points for amendments to the immunization law: the compensation remedy for vaccine-associated adverse events...

Descripción completa

Detalles Bibliográficos
Autor principal: Nakayama, Tetsuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Japan 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3824286/
https://www.ncbi.nlm.nih.gov/pubmed/23835871
http://dx.doi.org/10.1007/s10156-013-0641-6
_version_ 1782290686190551040
author Nakayama, Tetsuo
author_facet Nakayama, Tetsuo
author_sort Nakayama, Tetsuo
collection PubMed
description The concept of immunization was started in Japan in 1849 when Jenner’s cowpox vaccine seed was introduced, and the current immunization law was stipulated in 1948. There have been two turning points for amendments to the immunization law: the compensation remedy for vaccine-associated adverse events in 1976, and the concept of private vaccination in 1994. In 1992, the regional Court of Tokyo, not the Supreme Court, decided the governmental responsibility on vaccine-associated adverse events, which caused the stagnation of vaccine development. In 2010, many universal vaccines became available as the recommended vaccines, but several vaccines, including mumps, zoster, hepatitis B, and rota vaccines, are still voluntary vaccines, not universal routine applications. In this report, immunization strategies and vaccine development are reviewed for each vaccine item and future vaccine concerns are discussed.
format Online
Article
Text
id pubmed-3824286
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Springer Japan
record_format MEDLINE/PubMed
spelling pubmed-38242862013-11-21 Vaccine chronicle in Japan Nakayama, Tetsuo J Infect Chemother Review Article The concept of immunization was started in Japan in 1849 when Jenner’s cowpox vaccine seed was introduced, and the current immunization law was stipulated in 1948. There have been two turning points for amendments to the immunization law: the compensation remedy for vaccine-associated adverse events in 1976, and the concept of private vaccination in 1994. In 1992, the regional Court of Tokyo, not the Supreme Court, decided the governmental responsibility on vaccine-associated adverse events, which caused the stagnation of vaccine development. In 2010, many universal vaccines became available as the recommended vaccines, but several vaccines, including mumps, zoster, hepatitis B, and rota vaccines, are still voluntary vaccines, not universal routine applications. In this report, immunization strategies and vaccine development are reviewed for each vaccine item and future vaccine concerns are discussed. Springer Japan 2013-07-09 2013 /pmc/articles/PMC3824286/ /pubmed/23835871 http://dx.doi.org/10.1007/s10156-013-0641-6 Text en © The Author(s) 2013 https://creativecommons.org/licenses/by/2.0/ Open AccessThis article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.
spellingShingle Review Article
Nakayama, Tetsuo
Vaccine chronicle in Japan
title Vaccine chronicle in Japan
title_full Vaccine chronicle in Japan
title_fullStr Vaccine chronicle in Japan
title_full_unstemmed Vaccine chronicle in Japan
title_short Vaccine chronicle in Japan
title_sort vaccine chronicle in japan
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3824286/
https://www.ncbi.nlm.nih.gov/pubmed/23835871
http://dx.doi.org/10.1007/s10156-013-0641-6
work_keys_str_mv AT nakayamatetsuo vaccinechronicleinjapan